These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 24480263)

  • 21. Practically achievable maximum high-risk clinical target volume doses in MRI-guided intracavitary brachytherapy for cervical cancer: a planning study.
    Menon G; Huang F; Sloboda R; Pearcey R; Ghosh S
    Brachytherapy; 2014; 13(6):572-8. PubMed ID: 25085455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Image-guided intracavitary high-dose-rate brachytherapy for cervix cancer: A single institutional experience with three-dimensional CT-based planning.
    Wang B; Kwon A; Zhu Y; Yeo I; Henson CF
    Brachytherapy; 2009; 8(2):240-247. PubMed ID: 19230789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer.
    Pelloski CE; Palmer M; Chronowski GM; Jhingran A; Horton J; Eifel PJ
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):131-7. PubMed ID: 15850913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cone beam CT-based three-dimensional planning in high-dose-rate brachytherapy for cervical cancer.
    Al-Halabi H; Portelance L; Duclos M; Reniers B; Bahoric B; Souhami L
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1092-7. PubMed ID: 19879059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of bladder distension on organs at risk in 3D image-based planning of intracavitary brachytherapy for cervical cancer.
    Kim RY; Shen S; Lin HY; Spencer SA; De Los Santos J
    Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):485-9. PubMed ID: 19467797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reporting and validation of gynaecological Groupe Euopeen de Curietherapie European Society for Therapeutic Radiology and Oncology (ESTRO) brachytherapy recommendations for MR image-based dose volume parameters and clinical outcome with high dose-rate brachytherapy in cervical cancers: a single-institution initial experience.
    Mahantshetty U; Swamidas J; Khanna N; Engineer R; Merchant NH; Deshpande DD; Shrivastava S
    Int J Gynecol Cancer; 2011 Aug; 21(6):1110-6. PubMed ID: 21633296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of ICRU point doses and volumetric doses of organs at risk (OARs) in brachytherapy for cervical cancer.
    Vinod SK; Caldwell K; Lau A; Fowler AR
    J Med Imaging Radiat Oncol; 2011 Jun; 55(3):304-10. PubMed ID: 21696566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bladder distension improves the dosimetry of organs at risk during intracavitary cervical high-dose-rate brachytherapy.
    Harmon G; Chinsky B; Surucu M; Harkenrider M; Small W
    Brachytherapy; 2016; 15(1):30-4. PubMed ID: 26521661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative assessment of doses to tumor, rectum, and bladder as evaluated by orthogonal radiographs vs. computer enhanced computed tomography-based intracavitary brachytherapy in cervical cancer.
    Datta NR; Srivastava A; Maria Das KJ; Gupta A; Rastogi N
    Brachytherapy; 2006; 5(4):223-9. PubMed ID: 17118314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaginal dose de-escalation in image guided adaptive brachytherapy for locally advanced cervical cancer.
    Mohamed S; Lindegaard JC; de Leeuw AA; Jürgenliemk-Schulz I; Kirchheiner K; Kirisits C; Pötter R; Tanderup K
    Radiother Oncol; 2016 Sep; 120(3):480-485. PubMed ID: 27267048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comprehensive evaluation of adaptive daily planning for cervical cancer HDR brachytherapy.
    Meerschaert R; Nalichowski A; Burmeister J; Paul A; Miller S; Hu Z; Zhuang L
    J Appl Clin Med Phys; 2016 Nov; 17(6):323-333. PubMed ID: 27929505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison between DVH-based doses and ICRU point-based doses to the rectum and the bladder using CT-based high-dose rate brachytherapy to the cervix.
    Rangarajan R; Subramanian S; Gopalakrishnan K
    Med Dosim; 2018 Autumn; 43(3):276-283. PubMed ID: 29198390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulsed-dose rate image-guided adaptive brachytherapy in cervical cancer: Dose-volume effect relationships for the rectum and bladder.
    Mazeron R; Maroun P; Castelnau-Marchand P; Dumas I; del Campo ER; Cao K; Slocker-Escarpa A; M'Bagui R; Martinetti F; Tailleur A; Guemnie-Tafo A; Morice P; Chargari C; Lefkopoulos D; Haie-Meder C
    Radiother Oncol; 2015 Aug; 116(2):226-32. PubMed ID: 26164773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rectal and bladder dose reduction with the addition of intravaginal balloons to vaginal packing in intracavitary brachytherapy for cervical cancer.
    Eng TY; Patel AJ; Ha CS
    Brachytherapy; 2016; 15(3):312-318. PubMed ID: 27032995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose rate in the highest irradiation area of the rectum correlates with late rectal complications in patients treated with high-dose-rate computed tomography-based image-guided brachytherapy for cervical cancer.
    Isohashi F; Akino Y; Matsumoto Y; Suzuki O; Seo Y; Tamari K; Sumida I; Sawada K; Ueda Y; Kobayashi E; Tomimatsu T; Nakanishi E; Nishi T; Kimura T; Ogawa K
    J Radiat Res; 2021 May; 62(3):494-501. PubMed ID: 33866361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of conventional and CT-based planning for intracavitary brachytherapy for cervical cancer: target volume coverage and organs at risk doses.
    Onal C; Arslan G; Topkan E; Pehlivan B; Yavuz M; Oymak E; Yavuz A
    J Exp Clin Cancer Res; 2009 Jul; 28(1):95. PubMed ID: 19570212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bladder-rectum spacer balloon in high-dose-rate brachytherapy in cervix carcinoma.
    Rai B; Patel FD; Chakraborty S; Sharma SC; Kapoor R; Aprem AS
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):e217-22. PubMed ID: 23517809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaginal packing volume impact on dose parameters during radiography and computed tomography based postoperative brachytherapy of cervical carcinoma.
    Tomasevic A; Plesinac-Karapandzic V; Stojanovic-Rundic S; Vuckovic S; Stevanovic J; Gavrilovic D; Nadrljanski M
    J BUON; 2017; 22(6):1509-1516. PubMed ID: 29332346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variable impact of intracavitary brachytherapy fractionation schedule on biologically effective dose to organs at risk in patients with cervical cancer.
    Christensen EN; Yu HZ; Klopp AH; Tsai JC; Lawyer AA; Court LE; Eifel PJ
    Brachytherapy; 2014; 13(3):240-9. PubMed ID: 24188993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 45 or 50 Gy, Which is the Optimal Radiotherapy Pelvic Dose in Locally Advanced Cervical Cancer in the Perspective of Reaching Magnetic Resonance Image-guided Adaptive Brachytherapy Planning Aims?
    Mazeron R; Petit C; Rivin E; Limkin E; Dumas I; Maroun P; Annede P; Martinetti F; Seisen T; Lefkopoulos D; Chargari C; Haie-Meder C
    Clin Oncol (R Coll Radiol); 2016 Mar; 28(3):171-7. PubMed ID: 26547694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.